PHARMACEUTICAL COMPOSITION CONTAINING LORATADINE AND LEUKOTRIENE ANTAGONIST

摘要

Novel composition comprises as active ingredients loratadine and a leukotriene antagonist, selected from: (a) montelukast sodium; (b) sodium-1-((R)-(3-(2-(6,7-difluoro-2-quinolinyl)ethenyl)phenyl)-3-(2-(2-hydroxy-2-propyl)phenyl)thio)methylcyclopropaneacetate; (c) 1-(((1(R)-(3-(2-(2,3-dichlorothieno[3,2-b]pyridin-5-yl)-(E)-ethenyl)phenyl)-3-(2-(1-hydroxy-1-methylethyl) phenyl)propyl)thio)methyl)cyclopropaneacetic acid or a sodium salt; (d) pranlukast; and (e) zafirlukast.